Picture of Ginkgo Bioworks Holdings logo

DNA — Ginkgo Bioworks Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Ginkgo Bioworks Holdings Inc reports results for the quarter - Earnings Summary

* Ginkgo Bioworks Holdings Inc  DNA.N  reported a quarterly
adjusted loss of 94 cents​​ per share for the quarter , higher
than the same quarter last year, when the company reported EPS
of $-6.40.  The mean expectation of five analysts for the
quarter was for a loss of $2.72 per share. Wall Street expected
results to range from $-2.99 to $-2.40 per share.
    * Revenue rose 60.6% to $89.05 million from a year ago;
analysts
expected $45.00 million. 
    * Ginkgo Bioworks Holdings Inc's reported EPS for the
quarter was
a loss of $1.08​.
    * The company reported a quarterly loss of $56.4 million.
    * Ginkgo Bioworks Holdings Inc shares had risen by 2.9% this
quarter and lost 87.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 4 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "sell"

Wall Street's median 12-month price target for Ginkgo Bioworks
Holdings Inc is $8.00 
This summary was machine generated from LSEG data November 13 at
02:20 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -2.72          -0.94          Beat
 Jun. 30 2024      -3.12          -2.80          Beat
 Mar. 31 2024      -3.33          -3.20          Beat
 Dec. 31 2023      -3.87          -4.40          Missed

Recent news on Ginkgo Bioworks Holdings

See all news